VICASINABIN

UNII:	QJ8UO6C05M
Type:	INGREDIENT SUBSTANCE
Formula:	C₁₅H₂₂N₁₀O
Preferred Substance Name:	VICASINABIN
InChIKey:	MAYZWDRUFKUGGP-VIFPVBQESA-N
GSRS Full Record:	QJ8UO6C05M i

1433361-02-4
(3S)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol
(3S)-1-{5-tert-butyl-3-[(1-methyl-1H-tetrazol-5-yl)methyl]-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl{pyrrolidin-3-ol
(S)-1-(5-TERT-BUTYL-3-((1-METHYL-1H-TETRAZOL-5-YL)METHYL)-3H-(1,2,3)TRIAZOLO-(4,5-D)PYRIMIDIN-7-YL)PYRROLIDIN-3-OL
3-Pyrrolidinol, 1-[5-(1,1-dimethylethyl)-3-[(1-methyl-1H-tetrazol-5-yl)methyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-7-yl]-, (3S)-
RG-7774
RG7774
RO-6868847
RO6868847
VICASINABIN [USAN]
Vicasinabin
vicasinabin [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

VICASINABIN

Synonyms and Mappings

Resources